Growth hormone treatment in Léri-Weill syndrome

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue 2, 1996, Pages 201-204

  Thuestad, Inger Johanne ^a,b   Ivarsson, Sten Anders ^a   Nilsson, Karl Olof ^a   Wattsgård, Cecilia ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHONDRODYSPLASIA; CLINICAL ARTICLE; FEMALE; GROWTH RETARDATION; HUMAN; MALE; SCHOOL CHILD;

ADOLESCENT; ARGININE; BODY HEIGHT; BODY WEIGHT; CHILD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; MALE; OSTEOCHONDRODYSPLASIAS; SYNDROME;

EID: 0029930849     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Léri A, Weill J. Une affection congénitale et symétrique du développment osseux: la dyschondrostéose. Bull Soc Méd Hop Paris 1929; 53: 1491-1494.
2. Kaitila II, Leisti JT, Rimoin DL. Mesomelic skeletal dysplasia. Clin Orthop Rel Res 1976; 114: 94-106.
3. Madelung O. Die spontane Subluxation der Hand nach vorne Arch Klin Chir 1878; 23: 395-412.
4. Bridges NA, Hindmarsh PC, Brook CGD. Growth of children with hypochondroplasia treated with growth hormone for up to three years. Horm Res 1991; 36 (suppl 1): 56-60.
5. Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S, Compton P, Frane J, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, New MI, Saenger P, Sybert V. Threeyear results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. J Pediatr 1988; 113: 393-400.